Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $203,000 | $139,800 | $246,200 | $216,500 |
| % Growth | 45.2% | -43.2% | 13.7% | – |
| Cost of Goods Sold | $74,900 | $123,300 | $127,700 | $114,500 |
| Gross Profit | $128,100 | $16,500 | $118,500 | $102,000 |
| % Margin | 63.1% | 11.8% | 48.1% | 47.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | -$11,000 | $58,600 | $84,400 | $70,300 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,000 | $14,700 | $20,100 | $18,000 |
| Operating Expenses | -$10,000 | $73,300 | $104,500 | $88,300 |
| Operating Income | $125,600 | -$56,800 | $41,400 | -$15,100 |
| % Margin | 61.9% | -40.6% | 16.8% | -7% |
| Other Income/Exp. Net | $382,200 | -$216,700 | -$526,200 | -$32,800 |
| Pre-Tax Income | $644,000 | -$273,500 | -$484,800 | -$22,300 |
| Tax Expense | $43,100 | -$48,500 | $5,200 | -$6,000 |
| Net Income | $600,900 | -$225,000 | -$490,000 | -$16,300 |
| % Margin | 296% | -160.9% | -199% | -7.5% |
| EPS | 3.41 | -1.27 | -2.78 | -0.094 |
| % Growth | 368.5% | 54.3% | -2,848% | – |
| EPS Diluted | 3.41 | -1.27 | -2.78 | -0.094 |
| Weighted Avg Shares Out | 176,294 | 177,419 | 176,350 | 172,762 |
| Weighted Avg Shares Out Dil | 176,294 | 177,419 | 176,350 | 172,762 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6,000 | $6,000 | $4,600 | $4,000 |
| Depreciation & Amortization | $200 | -$163,800 | $21,900 | $19,700 |
| EBITDA | $125,800 | -$220,600 | $90,700 | $4,600 |
| % Margin | 62% | -157.8% | 36.8% | 2.1% |